Skip to content

HDAC Inhibitors as Epigenetic Regulators

HDAC Inhibitor

Day: February 18, 2022

  • Home
  • 2022
  • February
  • 18
  • p60c-src
 Posted on February 18, 2022

In contrast to its proto-oncogenic counterpart c-ABL, BCR-ABL displays constitutive tyrosine kinase activity

In contrast to its proto-oncogenic counterpart c-ABL, BCR-ABL displays constitutive tyrosine kinase activity.1 The ATP-competitive BCR-ABL tyrosine kinase inhibitor imatinib…

In contrast to its proto-oncogenic counterpart c-ABL, BCR-ABL displays constitutive tyrosine kinase activity Read More

Recent Posts

  • The C532A-E/A mutant showed higher levels of the monomeric form (Fig
  • GSTFBP17 (individual) and wild-type or IST mutant of GSTToca-1 (rat) were expressed in Sf9 cells using the Bac-to-Bac Baculovirus Appearance System (Invitrogen) and were purified with glutathione Sepharose 4B (GE Life Sciences), as described earlier (Suetsuguet al, 2006a)
  • Medium was collected after 24h and 48h tradition
  • The Immunovirology Analysis Network (IVRN) provided these samples
  • All reported local and systemic solicited reactogenicity was mild to moderate in severity

Recent Comments

  • A WordPress Commenter on Hello world!
eCommerce Plus Theme